within the rapidly evolving discipline of oncology investigation, exact and productive mutation screening is essential for building specific therapies. The KRAS solutions System plays a pivotal function With this landscape by featuring detailed options for KRAS mutation profiling and analysis. KRAS mutations, present in approximately ninety five% o